Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pittrow

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Clinical Investigation|April 2, 2009
Update on endothelin-related diseasesD Pittrow, W Kirch
European Journal of Clinical Investigation|April 2, 2009
Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidenceW Neuhofer, D Pittrow
European Journal of Clinical Investigation|August 22, 2006
Dual endothelin receptor antagonism in pulmonary arterial hypertensionD Pittrow, W Kirch
European Journal of Clinical Investigation|August 22, 2006
Role of endothelin and endothelin receptor antagonists in renal diseaseW Neuhofer, D Pittrow
Rheumatology (Oxford, England)|September 22, 2006
Endothelin in human autoimmune diseases with renal involvementW Neuhofer, D Pittrow
Current Medical Research and Opinion|October 7, 2004
The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary careP Bramlage, D Pittrow, W Kirch
Deutsche Medizinische Wochenschrift (1946)|March 12, 2010
[Presentation and management of atrial fibrillation: current state and perspective for research]T Meinertz, D Pittrow, W Kirch
Deutsche Medizinische Wochenschrift (1946)|September 27, 2002
[Use of drugs in residents of homes for the elderly and nursing homes in comparison with patients in ambulatory care or without need of care]D Pittrow, J Krappweis, W Kirch
European Journal of Clinical Investigation|February 11, 2005
Factor Xa inhibitionP Bramlage, D Pittrow, W Kirch
European Journal of Clinical Investigation|February 11, 2005
Current concepts for the prevention of venous thromboembolismP Bramlage, D Pittrow, W Kirch
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Investigation|April 2, 2009
Update on endothelin-related diseasesD Pittrow, W Kirch
European Journal of Clinical Investigation|April 2, 2009
Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidenceW Neuhofer, D Pittrow
European Journal of Clinical Investigation|August 22, 2006
Dual endothelin receptor antagonism in pulmonary arterial hypertensionD Pittrow, W Kirch
European Journal of Clinical Investigation|August 22, 2006
Role of endothelin and endothelin receptor antagonists in renal diseaseW Neuhofer, D Pittrow
Rheumatology (Oxford, England)|September 22, 2006
Endothelin in human autoimmune diseases with renal involvementW Neuhofer, D Pittrow
Current Medical Research and Opinion|October 7, 2004
The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary careP Bramlage, D Pittrow, W Kirch
Deutsche Medizinische Wochenschrift (1946)|March 12, 2010
[Presentation and management of atrial fibrillation: current state and perspective for research]T Meinertz, D Pittrow, W Kirch
Deutsche Medizinische Wochenschrift (1946)|September 27, 2002
[Use of drugs in residents of homes for the elderly and nursing homes in comparison with patients in ambulatory care or without need of care]D Pittrow, J Krappweis, W Kirch
European Journal of Clinical Investigation|February 11, 2005
Factor Xa inhibitionP Bramlage, D Pittrow, W Kirch
European Journal of Clinical Investigation|February 11, 2005
Current concepts for the prevention of venous thromboembolismP Bramlage, D Pittrow, W Kirch
Pageof 8